Haleos Labs Ltd

Haleos Labs Business Update

USFDA inspected the material subsidiary Mahi Drugs' API facility in Parawada. The inspection concluded with zero Form 483 observations.

Haleos Labs Other Announcement

Haleos Labs Ltd notified shareholders of the Annual Report and AGM notice weblink, while requesting updates to their KYC and email addresses.

Haleos Labs Annual Report

Haleos Labs Ltd has submitted its Annual Report for the financial year 2025-26, along with the Notice for its 20th Annual General Meeting.

Haleos Labs Dividend

Haleos Labs Limited recommended a final dividend of ₹15 per equity share for FY 2025-26. The record date is fixed for September 23, 2026.

Haleos Labs Annual General Meeting

Haleos Labs Limited announced postal ballot results where shareholders approved director reappointment and related party transactions. However, a resolution for managerial remuneration was rejected by shareholders.

Haleos Labs Management Change

Haleos Labs Limited has re-appointed Dr. Mannam Malakondaiah and Dr. Srinivas Samavedam as Independent Directors for five-year terms starting November 13, 2026. Shareholder approval is required.

Execution

5 years

Haleos Labs Q1 FY27 Results: Net Profit ₹1.8 Cr, Down 59.1% YoY

Haleos Labs Ltd reported revenue from operations of ₹72.9 Cr (-11.6% YoY) and net profit of ₹1.8 Cr (-59.1% YoY) for Q1 FY27.

Key figure

Net profit ₹1.8 Cr · -59.1% YoY

Haleos Labs Board Meeting Date

Haleos Labs Ltd has scheduled a board meeting for August 5, 2026, to consider and approve its unaudited financial results for the quarter ended June 30, 2026.

Haleos Labs Annual General Meeting

Haleos Labs Limited issued a postal ballot notice seeking shareholder approval for director reappointment, managerial remuneration limits, and material related party transactions.

Value

₹190.7 Cr

Haleos Labs Annual General Meeting

Haleos Labs Limited issued a postal ballot notice for shareholder approval regarding director reappointment, managerial remuneration, and various material related party transactions.

Value

₹200.6 Cr

Haleos Labs Annual General Meeting

Haleos Labs has announced a postal ballot process to seek shareholder approval for various resolutions, including director reappointment, managerial remuneration, and related party transactions.